Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Oncotarget|December 31, 2016
Epigenetic therapy in urologic cancers: an update on clinical trialsInês Faleiro, Ricardo Leão, Alexandra Binnie, et al.
Molecular Medicine Reports|May 12, 2012
Retinoblastoma and p53 protein expression in pre-malignant oral lesions and oral squamous cell carcinomaMarília Gerhardt de Oliveira, Luciana Maria Pereira Ramalho, Leonilson Gaião, et al.
Pharmacogenomics|February 26, 2015
Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapiesInês de Paula Costa Monteiro, Pedro Madureira, Alessandro de Vasconscelos, et al.
Recent Patents on DNA & Gene Sequences|January 14, 2012
Insight into p95HER2 in breast cancer: molecular mechanisms and targeted therapiesRamon Andrade de Mello, Alessandro de Vasconcelos, Ronaldo A Ribeiro, et al.
Cancers|September 28, 2023
Update in Immunotherapy for Advanced Non-Small Cell Lung Cancer: Optimizing Treatment Sequencing and Identifying the Best ChoicesKatia Roque, Rossana Ruiz, Luis Mas, et al.
Plos One|September 17, 2013
The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancerRamon Andrade de Mello, Mónica Ferreira, Filipa Soares-Pires, et al.
Oncotarget|March 17, 2018
Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: a network meta-analysisRamon Andrade De Mello, Carles Escriu, Pedro Castelo-Branco, et al.
Journal of Clinical Medicine|November 6, 2020
New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future PerspectivesRamon Andrade de Mello, Nathália Moisés Neves, Hakaru Tadokoro, et al.
Future Oncology (London, England)|October 12, 2017
The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancerInês Faleiro, Joana Dias Apolónio, Aryeh J Price, et al.
Immunotherapy|August 4, 2018
Cost-effectiveness and budget impact of lung cancer immunotherapy in South America: strategies to improve accessPedro Aguiar, Auro Del Giglio, Luke Alastair Perry, et al.
Pageof 7